Results 241 to 250 of about 123,463 (303)

A Novel Mechanism of Salvianolic Acid B in Postmyocardial Infarction Cardiac Protection: PHB1‐Driven Raf‐ERK Pathway Activation Promotes Cardiomyocyte Mitosis

open access: yesMedComm, Volume 7, Issue 5, May 2026.
SalB binds to the C‐terminal of PHB1/2 heterodimer, inducing a conformational change that enhances Raf‐ERK pathway activation via Akt‐mediated phosphorylation, thereby promoting cardiomyocyte mitosis. ABSTRACT Heart failure (HF) following myocardial infarction remains a leading cause of global morbidity and mortality, necessitating novel therapeutic ...
Ce Cao   +10 more
wiley   +1 more source

Efferocytosis: Signaling Pathways and New Therapeutic Strategies for Diseases

open access: yesMedComm, Volume 7, Issue 5, May 2026.
1. Efferocytosis coordinates molecular signaling and metabolic reprogramming to resolve inflammation. 2. Efferocytosis dysfunction underlies four conserved pathological hallmarks across diseases. 3. Therapeutic strategies targeting efferocytosis should be context‐dependent: enhance or inhibit based on disease type. ABSTRACT Efferocytosis—the phagocytic
Lei Wang   +6 more
wiley   +1 more source

S-nitrosoglutathione preserves vasodilation and attenuates myocardial ischemia-reperfusion injury. [PDF]

open access: yesSci Rep
Guizoni DM   +5 more
europepmc   +1 more source

NMRK2-YAP-NADK axis preserves redox protection against myocardial ischemia/reperfusion injury. [PDF]

open access: yesRedox Biol
Zhang C   +13 more
europepmc   +1 more source

Myocardial ischemia reperfusion in diabetes: mechanism of injury and its drug treatment. [PDF]

open access: yesDiabetol Metab Syndr
Duan PH   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy